Founded in 1994, the Angiogenesis Foundation is the world’s first 501(c)(3) nonprofit organization dedicated to conquering disease using a new approach based on angiogenesis, the growth of new capillary blood vessels in the body. We have identified angiogenesis as the “common denominator” in society’s most feared diseases. Our focus on this underlying process of many different diseases makes our approach as a medical organization unique. The Foundation is the recognized, expert voice and champion of this new field of medicine.

Based in Cambridge, Massachusetts, the Angiogenesis Foundation’s goal is to help people lead healthier, longer lives by restoring balance to blood vessel growth. Through research, education, and advocacy — with patients, physicians, researchers, industry, payers, and government — we enable patients to gain access to safe and effective treatments coming from the angiogenesis field for cancer, blinding diseases, wounds, and many other serious diseases.

As a scientific organization, the Angiogenesis Foundation is independent of any individual, institution, or commercial entity. We are committed to helping people around the world benefit from the full promise of angiogenesis-based medicine, and to make life-, limb-, and vision-saving treatments available to everyone in need.

Health Care

Life Sciences

Medical Devices

Non Profit

The Angiogenesis Foundation

The Angiogenesis Foundation's headquarters in Cambridge, MA, United States

Dr. William Li

Robert A. Figlin

Rebecca Suk Heist

Nancy Klauber - Demore

Jeffrey Isner

Howard Green

Dimitri Yellachich

Chung - May Yang

Rainier Iii

Paul Dudley

John T. Thompson

Dirk Arnold

Carl Hayden

Alain C. Mita

Vickie R. Driver

Sara Tolaney

Romeo Martini

Horacio Astudillo De La Vega

Craig Flanagan

Carl W. Baker

Akila Viswanathan

Juliana Figueiredo

Maria L. Aufiero

Zigang Dong

Description

People (2)

Maria L. Aufiero

Courtney M.

Jobs